IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJ-D-15-00484

Spontaneous enlargement of pulmonary artery after successful balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension

Shinya Nagayoshi1, MD; Aiko Ogawa2, MD, PhD; Hiromi Matsubara1,2*, MD, PhD

A 72-year-old woman with inoperable chronic thromboembolic pulmonary hypertension underwent balloon pulmonary angioplasty (BPA). Intravascular ultrasound (Eagle Eye® Platinum; Volcano Corp., San Diego, CA, USA) revealed severe stenosis in the right A8 with a narrow vessel distal to the lesion (Panel Aa, Panel Ab). According to a pressure wire (Primewire Prestige® PLUS; Volcano Corp.) measurement, the pulmonary artery pressure distal to the lesion was much lower than that proximal to the lesion with little pulse pressure (Panel Ac). Immediately after the dilation with a 2.5 mm balloon catheter (IKAZUCHI PAD; Kaneka, Osaka, Japan) at 14 atm, the vessel diameter distal to the lesion expanded, although the vessel diameter at the lesion was unchanged and angiographic stenosis was still observed (Panel Ba, Panel Bb). The pulmonary artery pressure distal to the lesion increased as a result of the improved blood flow (Panel Bc). Next, the right A7 and A10 were also treated. Three months later, angiographic stenosis and the blood flow improved even more, although no additional treatment was performed at the lesion. Intravascular ultrasound observations revealed dilatation of the lumen diameter and the blood flow improved (Panel Ca, Panel Cb), effectively eliminating the pressure gradient across the lesion (Panel Cc).

Increase in perfusion pressure in the pulmonary artery distal to the obstruction with partial detachment of the organised thrombi may be a driving force to dilate pulmonary arteries spontaneously over time without causing restenosis after BPA. Thus, the immediate elimination of the pressure gradient may not be necessary for the long-term success of BPA.

Conflict of interest statement

H. Matsubara has received lecture fees from GlaxoSmithKline K.K., Actelion Pharmaceuticals Japan Ltd., and Pfizer Japan Inc. The other authors have no conflicts of interest to declare.

Volume 12 Number 11
Dec 9, 2016
Volume 12 Number 11
View full issue


Key metrics

Suggested by Cory

Image – Interventional flashlight

10.4244/EIJ-D-18-01212 Oct 4, 2019
Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension
Räber L et al
free

10.4244/EIJV12SXA8 May 16, 2016
Percutaneous treatment of chronic thromboembolic pulmonary hypertension (CTEPH)
Muller DW and Liebetrau C
free
Trending articles
151.43

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
55.9

Clinical research

10.4244/EIJ-D-22-00621 Feb 20, 2023
Long-term changes in coronary physiology after aortic valve replacement
Sabbah M et al
free
54.9

Expert review

10.4244/EIJ-D-21-01010 Jun 24, 2022
Device-related thrombus following left atrial appendage occlusion
Simard T et al
free
43.75

Clinical Research

10.4244/EIJ-D-21-01091 Aug 5, 2022
Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study
Medranda G et al
free
39.95

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved